NeuroBo Pharmaceuticals Inc Stock price
Is NeuroBo Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
NeuroBo Pharmaceuticals Inc Stock Analysis
Analyst Opinions
8 Analysts have issued a NeuroBo Pharmaceuticals Inc forecast:
Analyst Opinions
8 Analysts have issued a NeuroBo Pharmaceuticals Inc forecast:
Don't miss a Thing! We will send you all news about NeuroBo Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
NeuroBo Pharmaceuticals Inc Stock News
Company Profile
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
| Head office | United States |
| CEO | Mr. Kim |
| Employees | 8 |
| Founded | 2014 |
| Website | metaviatx.com |


